Topics

General medicine

Ethics Letters 1 August 2016 Free

English as a second language and outcomes of patients presenting with acute coronary syndromes: results from the CONCORDANCE registry

To the Editor:The retrospective observational study by Juergens and colleagues1 raises some concerning questions. They chose the variable of English either as first language (EFL) or second language (ESL) and measured significant inferiority of care and outcome for people with ESL. This variable has the advantage of being reasonably easy to collect in a standardised way, but the effect that is being measured is likely to be a proxy for limited English proficiency. We do not need a large trial to know that a patient who is unable to communicate with his or her doctor will have inferior care and outcomes. To be able to provide clinical care, we need to know the language proficiency of the patient. To assess the outcome of the clinical care using an EFL or ESL variable, we need to know whether an interpreter was used and if the interpreter was professional or ad hoc. The authors acknowledge this omission, but they make the contentious statement that “using non-professional interpreters can be expedient”. I would argue that in the setting of an admission for acute coronary syndrome, where vital issues of informed consent and patient understanding of the condition are involved, the use of non-professional interpreters is unethical.2 This is particularly true in Australia where, as Phillips notes, “the Translating and Interpreting Service offers the most extensive telephone interpreting system in the world, providing doctors and pharmacists with rapid, 24-hour access to interpreters”.3 Although, as the authors point out, we cannot know how much of this adverse outcome in correlation with ESL is related to poor communication and how much is related to a higher prevalence of cardiovascular risk factors, it is inconceivable that poor communication is not part of the explanation. A professional interpreter should be used routinely in the setting of an admission for acute coronary syndrome because this will almost certainly improve outcomes4 and is likely to decrease costs,5 and it is a basic right for a patient to be able to communicate fully with clinicians when suffering from a potentially fatal illness.

Ben Gray

Guideline for the diagnosis and management of hypertension in adults — 2016

Updated recommendations from the National Heart Foundation take into account the findings of recent meta-analyses, systematic reviews and randomised controlled trials

Genevieve M Gabb · Arduino A Mangoni · Craig S Anderson · Diane Cowley · John S Dowden · Jonathan Golledge · Graeme J Hankey · Faline S Howes · Les Leckie · Vlado Perkovic · Markus Schlaich · Nicholas A Zwar · Tanya L Medley · Leonard Arnolda

16 00526
Anaesthetics Clinical focus 2 May 2016 Free

Acute pain management: scientific evidence, fourth edition, 2015

The increase in evidence over the past 15 years in acute pain management is impressive

Stephan A Schug MD, FANZCA, FPMANZCA · Greta M Palmer MB BS, FANZCA, FFPMANZCA · David A Scott PhD, FANZCA, FFPMANZCA · Richard Halliwell MB BS, FANZCA · Jane Trinca MM(Pain Management), FANZCA, FPPMANZCA

16 00133

Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia

An estimated 970 000 Australians may not be receiving recommended combination blood pressure- and lipid-lowering therapy

Emily Banks MB BS, PhD, FAFPHM · Simon R Crouch MB BS, PhD, FAFPHM · Rosemary J Korda PhD · Bill Stavreski BEcon, MPPM · Karen Page RN, MNursStud, BEd · Katherine A Thurber MPhil · Robert Grenfell MB BS, MPH, FAFPHM

15 01004

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.